The pharmacokinetics and protein binding of ceforanide were studied in 15 patients undergoing cholecystectomies. Each patient received ceforanide (20 mg/kg) intravenously on arrival in the operating room, after which serial blood samples were collected during the elimination phase for determination of total and free ceforanide concentrations in the serum. A high-pressure liquid chromatography assay was used, with a centrifugal filtration system for free-drug determinations. Serum concentration data for each individual were subjected to linear regression to determine the elimination rate constants (total and free drug), volumes of distribution, and systemic clearances. The mean elimination rate constants were 0.41 and 0.50 h-1 for total and free ceforanide, respectively. The mean percentage of ceforanide bound to serum protein was 87.9%. The relationship of the free ceforanide concentration to the total concentration appeared to be linear. The data were fit to double-reciprocal and half-reciprocal relationships with good agreement, showing one binding site and an association constant range of 1.6 x i07 to 1.9 x 107 at these in vivo concentrations. The mean volume of distribution and mean systemic clearance of total drug were 100 ml/kg and 45.9 ml/min per 1.73 in2, respectively. Ceforanide consistently produced higher intraoperative total drug concentrations compared with those of cefazolin and cefoxitin from similar studies.
The basic principle underlying the use of prophylactic antimicrobial agents is that the agent should be available during the time of potential bacterial contamination (2, 9) . For surgical prophylaxis, this critical period begins with the initial incision and continues, in most cases, until the wound is closed. Optimal use of antimicrobial agents for surgical prophylaxis requires the agent to be present during this entire interval (2) .
The availability of an antimicrobial agent at the site of potential contamination, the surgical wound, is related to the presence of antimicrobial agents in serum. Many factors affect tissue penetration by antimicrobial agents. When serum concentrations of beta-lactam antimicrobial agents are minimal, tissue concentrations are usually low. The transfer of an antibiotic into peripheral tissues is directly related to the area under the concentration versus the time curve for free drug (1) . This area is partially determined by the free fraction of drug circulating in serum.
We previously investigated the intraoperative concentrations of cefazolin and cefoxitin (3) . Considerable differences were observed in total drug concentrations throughout the operations. Cefazolin concentrations were two to three times higher than those of cefoxitin. Cefoxitin, the agent with a shorter elimination half-life, demonstrated that more frequent intraoperative readministration is needed.
Antimicrobial agents with relatively long elimination halflives may be advantageous since they could provide adequate concentrations in serum throughout the surgical procedure. Ceforanide was chosen for this study because of its relatively long elimination half-life of 3.0 h (7, (10) (11) (12) . The objective of this study was to determine the intraoperative pharmacokinetics and in vivo protein binding of ceforanide after preoperative, intravenous administration. trichloroacetic acid was added to precipitate proteins, and the solution was vortexed for 1 min. Acetonitrile (1 ml) was then added, and the mixture was centrifuged for 10 min at 2,500 x g. The supernatant was transferred to a tube containing 5 ml of methylene chloride, vortexed for 1 min, and then shaken for 10 min. After centrifugation, 100 pI of the aqueous-phase solution was injected into the high-pressure liquid chromatography apparatus. A standard curve for ceforanide-free acid was prepared by using final concentrations of 0, 2, 4, 8, 12, 16, 20, 30, 40, 60, 80, 100, and 120 ,ug of plasma per ml, with a resultant r of 0.999. The coefficients of variation were 1.7% at 2 ,ug/ml and 1.4% at 20 p.g/ml.
Free ceforanide was separated from bound ceforanide by using a centrifugal filtration system (Amicon micropartition system with YMT membranes). Serum was placed in the filtration system and centrifuged at 3,000 rpm for 20 min. Then 0.2 ml of filtrate was collected and mixed with the internal standard (20 ,u1), and the sample was injected directly into the high-pressure liquid chromatography column under the conditions above. The YMT membrane was tested for any loss of ceforanide that may have been caused by absorption on the membrane during the filtration process. Six aqueous solutions of ceforanide with concentrations varying from 5 to 100 ,ug/ml were used in duplicate, and the mean change in concentration from nonfiltered solution was from +1.43% at 5 p.g/ml to -0.71% at 100 jig/ml with a high value of 4.02% at 20 jig/ml. Data analysis. For each subject, data for total and free ceforanide concentrations in serum versus time were subjected to linear regression analysis to determine individual intraoperative elimination rate constants (Kel) assuming a one-compartment model. Differences in Kel for total and free ceforanide were tested by the Wilcoxon Rank Sum test (4) . From individual linear regression, concentrations were projected for standardized postinfusion times that corresponded to intraoperative events. Specifically, projected concentrations were determined for 30, 150, and 210 min postinfusion, corresponding to the appropriate time of initial incision and of closure for a 2-or 3-h operation, respectively.
The volume of distribution (V) was calculated for each individual from the back extrapolated total ceforanide concentration at time zero. Ceforanide systemic clearance (CL) was determined as the product of Kel and V.
Calculation of the binding parameters was performed in the following manner. (2) where n is the number of binding sites available on albumin and K is the association constant (15) . Since all of the ceforanide concentrations were within a relatively narrow range, it was a preliminary assumption that there was only one principle class of binding sites available. Equation 2 can be transformed in at least three different ways to obtain a linear relationship between r and A. The double-reciprocal relationship (6) results as follows: lr = (llnK)1/A + lln
The half-reciprocal relationship (8) is given as follows:
The Scatchard (9) relationship can be expressed as follows: rlA = Kn -Kr (5) Parameter estimates from equations 3, 4, and 5 were obtained by linear regression with a weighted least-squares method (lly) (8) .
RESULTS
The ages and weights of 15 patients who completed the investigation (3 male, 12 female) are given in Fig. 2 . The mean percentage of ceforanide bound to serum proteins was 87.9%. The mean V and mean CL of total drug were 100 ml/kg and 45.9 ml/min per 1.73 mi2, respectively. The relationship of the free concentration of ceforanide in serum to total ceforanide was linear over the range of drug concentrations used in this study. (3-h operation)
Concentrations of total and free ceforanide were projected from the linear regression data of each individual for times corresponding to key intraoperative events, as described previously. These results are summarized in Table 2 .
The number of binding sites and the association constant for the ceforanide-albumin in vivo binding interaction are given in Table 3 Fig. 3 .
DISCUSSION
Throughout the surgical procedures, ceforanide consistently produced high total drug concentrations in these patients relative to the values reported for cefazolin and cefoxitin by similar methods (3) . It appears that a single preoperative dose of ceforanide would provide a sufficient intraoperative antimicrobial concentration even for long operations (over 4 h).
The mean elimination half-life determined in this study is somewhat shorter than previously reported for normal volunteers (1.9 h versus 2.6 to 3.0 h, respectively) although CL is similar (7, (10) (11) (12) . The intraoperative serum protein binding for ceforanide is slightly greater than that reported for normal volunteers (87.9 versus 81%) (12) . Differences in reported parameters may have resulted from the conditions during the surgical procedures. No other reports are currently available in the literature describing intraoperative ceforanide pharmacokinetics other than in open-heart surgery with a cardiopulmonary bypass (5, 10). The stress and trauma imposed by the surgical incision as well as the administration of a multitude of medications preoperatively and intraoperatively (e.g., anesthetic gases, anticholinergic agents, and opiate derivatives) may affect drug pharmacokinetics, but differences between the study group and reported data from normal volunteers are not dramatic.
In this investigation, attempts were made to determine ceforanide binding parameters. Low binding ratios were present and used to calculate the in vivo binding parameters. 
